0000000000671376

AUTHOR

Tobias Breidthardt

showing 2 related works from this author

Effect of comprehensive vasodilation vs usual care on mortality and heart failure rehospitalization in women with acute heart failure

2020

Abstract Background Guidelines recommend evaluating the risk/benefit ratio of novel therapies individually in women and men, as the pathophysiology and the response to treatment may differ between women and men. Among patients with acute heart failure (AHF), a strategy of intensive vasodilation, compared with usual care, overall did provide comparable outcomes. Purpose To evaluate the effect of a strategy that emphasized early intensive and sustained vasodilation in women with AHF. Methods In a randomized, open-label blinded-end-point trial patients hospitalized for AHF were enrolled in 10 hospitals in Switzerland, Bulgaria, Germany, Brazil, and Spain. Inclusion criteria were AHF expressed …

medicine.medical_specialtybusiness.industryVasodilationmedicine.diseasePatient roomPharmacotherapyBlood pressurePlasma drug concentrationInternal medicineHeart failureUsual caremedicineCardiologyCardiology and Cardiovascular MedicineAdverse effectbusinessEuropean Heart Journal
researchProduct

Discordance in prognostic ability between physician assessed NYHA classification and self-reported health status in patients with acute heart failure

2021

Abstract Background Especially in patients with acute heart failure (AHF) the NYHA classification remains of uncertain representation of patients' actual health state. Alternatively, patient's subjective well-being, in terms of health-related quality of life (HRQL), showed to have an excellent prognostic ability in out clinic patients with chronic heart failure. Objectives It is unknown whether HRQL instruments can assess a more reliable prognostication in patients hospitalized due to AHF than the NYHA classification. Methods Goal Directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study (GALACTIC) was a multicenter, randomized, open-label blinded-end-point trial that em…

medicine.medical_specialtybusiness.industryInternal medicineHeart failureNYHA classificationMedicineIn patientCardiology and Cardiovascular Medicinebusinessmedicine.diseaseEuropean Heart Journal
researchProduct